Gainers
- Mesoblast MESO shares increased by 22.1% to $2.1 during Friday's pre-market session. The company's market cap stands at $180.2 million.
- Sangamo Therapeutics SGMO stock rose 20.27% to $0.5. The company's market cap stands at $88.6 million.
- Telesis Bio TBIO stock increased by 19.27% to $0.37. The market value of their outstanding shares is at $11.1 million.
- INVO Bioscience INVO stock rose 17.43% to $1.28. The company's market cap stands at $3.1 million.
- Coherus BioSciences CHRS stock increased by 14.99% to $2.76. The market value of their outstanding shares is at $307.3 million.
- TC BioPharm (Holdings) TCBP shares increased by 14.35% to $2.43. The company's market cap stands at $1.6 million.
Losers
- Esperion Therapeutics ESPR stock fell 17.7% to $1.77 during Friday's pre-market session. The market value of their outstanding shares is at $201.2 million.
- Adial Pharmaceuticals ADIL stock declined by 15.47% to $1.1. The market value of their outstanding shares is at $1.3 million.
- Accelerate Diagnostics AXDX shares fell 10.91% to $1.43. The market value of their outstanding shares is at $20.8 million.
- Alaunos Therapeutics TCRT stock declined by 9.47% to $0.12. The company's market cap stands at $29.9 million.
- Nuwellis NUWE stock decreased by 9.12% to $0.41. The company's market cap stands at $1.3 million.
- MorphoSys MOR stock declined by 8.7% to $9.35. The market value of their outstanding shares is at $1.4 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AXDXAccelerate Diagnostics Inc
$1.2713.5%
CHRSCoherus BioSciences Inc
$1.342.16%
ESPREsperion Therapeutics Inc
$2.09-5.00%
MESOMesoblast Ltd
$18.102.96%
NUWENuwellis Inc
$1.304.84%
SGMOSangamo Therapeutics Inc
$1.182.61%
TBIOTelesis Bio Inc
$0.480060.0%
TCBPTC BioPharm (Holdings) PLC
$0.3500-3.07%
TCRTAlaunos Therapeutics Inc
$2.0218.1%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in